insights_auto
Why is MYGN up ၄.၀၄%?
Dive Deeperchevron_right
MYGN:NASDAQ
Myriad Genetics Inc
၄.၂၄ US$
arrow_upward
+၄.၀၄%(+၀.၁၆) 1D
အောက် ၁၄, GMT-၄ ၁၅:၀၀:၅၄ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
၄.၀၈ US$
High
၄.၂၈ US$
Low
၄.၀၄ US$
Mkt. cap
၄၀.၆၀ ကုဋေ
Avg. vol.
၂.၀၃ သန်း
Volume
၆.၇၃ သိန်း
52-wk high
၈.၅၉ US$
52-wk low
၂.၇၄ US$
EPS
-၁.၂၀ US$
Beta
၁.၆၄
Shares outstanding
၉.၅၆ ကုဋေ
No. of employees
၃ ထောင်
Open
၄.၀၈ US$
High
၄.၂၈ US$
Low
၄.၀၄ US$
Mkt. cap
၄၀.၆၀ ကုဋေ
Avg. vol.
၂.၀၃ သန်း
Volume
၆.၇၃ သိန်း
52-wk high
၈.၅၉ US$
52-wk low
၂.၇၄ US$
EPS
-၁.၂၀ US$
Beta
၁.၆၄
Shares outstanding
၉.၅၆ ကုဋေ
No. of employees
၃ ထောင်
News stories
From web sources and news partners
Seeking Alpha
·
ပြီးခဲ့သည့် ၄၃ မိနစ်
Nasdaq tumbles 2%, and these 10 stocks have fueled the selloff
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
BSR REIT CEO on NYSE Listing, Texas Apartments and Growth Strategy
The Daily News | Texas' Oldest Newspaper
·
ပြီးခဲ့သည့် ၁ နာရီ
Federal Reserve Chair Jerome Powell interest rate announcement at the New York Stock Exchange (NYSE) in New York City
Barchart.com
·
ပြီးခဲ့သည့် ၁ နာရီ
US stocks sink as inflation gets worse
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz
Employees၂.၇ ထောင်
Founded၁၉၉၁
Headquartersဆော့်လိက် မြို့, ယူးတားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitemyriad.com